Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
817 studies found for:    "Hypertension, Pulmonary"
Show Display Options
RSS Create an RSS feed from your search for:
"Hypertension, Pulmonary"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Simvatstatin Used to Treat Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: simvastatin
2 Completed Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
3 Completed An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
4 Completed Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
5 Recruiting Effect of Exercise Training in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Behavioral: respiratory and exercise therapy;   Behavioral: respiratory and exercise therapy with supplemental oxygen
6 Completed Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
7 Recruiting Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
8 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo
9 Recruiting Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention:
10 Recruiting Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Acetazolamide;   Drug: Placebo
11 Active, not recruiting Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Hypertension, Pulmonary
Intervention: Other: Correlation assessment
12 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
13 Recruiting Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
14 Active, not recruiting Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
15 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
16 Terminated Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Terbogrel
17 Completed Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Terbogrel low dose;   Drug: Terbogrel high dose;   Drug: Placebo
18 Completed Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
19 No longer available Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Adempas (Riociguat, BAY63-2521)
20 Terminated
Has Results
Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
Condition: Pulmonary Hypertension
Intervention: Drug: Inhaled Iloprost

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.